|
NDEL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.876300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.578100E-02 |
| Normal-vs-Stage2 |
7.364500E-04 |
| Normal-vs-Stage3 |
2.062200E-02 |
| Normal-vs-Stage4 |
8.072400E-02 |
| Stage1-vs-Stage2 |
9.075700E-03 |
| Stage1-vs-Stage3 |
3.636800E-01 |
| Stage1-vs-Stage4 |
7.534000E-01 |
| Stage2-vs-Stage3 |
7.943700E-02 |
| Stage2-vs-Stage4 |
4.569600E-02 |
| Stage3-vs-Stage4 |
7.268800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.054400E-02 |
| Normal-vs-AfricanAmerican |
6.801800E-01 |
| Normal-vs-Asian |
1.677050E-01 |
| Caucasian-vs-AfricanAmerican |
3.601400E-01 |
| Caucasian-vs-Asian |
9.541000E-01 |
| AfricanAmerican-vs-Asian |
4.196200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.336360E-02 |
| Normal-vs-Female |
4.692100E-02 |
| Male-vs-Female |
2.327000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.927600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.126170E-02 |
| Normal-vs-Age(61-80Yrs) |
9.234600E-04 |
| Normal-vs-Age(81-100Yrs) |
6.650200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.403400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.433660E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.810000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.159600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.567200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.467200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.150420E-01 |
| Classical-VS-Follicular |
8.80406858527749E-14 |
| Classical-VS-Other |
2.946000E-01 |
| Classical-VS-Normal |
3.444600E-01 |
| Tall-VS-Follicular |
1.644480E-03 |
| Tall-VS-Other |
7.923800E-01 |
| Tall-VS-Normal |
3.987600E-02 |
| Follicular-VS-Other |
1.633590E-01 |
| Follicular-VS-Normal |
1.12720000000621E-06 |
| Other-VS-Normal |
2.566200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.408000E-04 |
| Normal-vs-N1 |
2.546000E-01 |
| N0-vs-N1 |
2.480200E-02 |
|
|
